ACHV
NASDAQ · Biotechnology
Achieve Life Sciences Inc
$7.75
+0.21 (+2.79%)
Analyst Consensus
Strong Buy
17
Analysts
High
Coverage
Price Target
Analyst Price Target
+311.5% upside
Low Target
$22.93
Average Target
$31.89
High Target
$41.27
Current Price
$7.75
Current
$7.75
$7.75
Target
$31.89
$31.89
$22.93
$31.89 avg
$41.27
Scenario Analysis
Bear Case
$22.93
195.9%
Low target
Base Case
$31.89
+311.5%
Avg target
Bull Case
$41.27
+432.5%
High target
Risk/Reward
2.2x
Favorable
Price in Context
52-Week High
$8.64
-10.3% from high
52-Week Low
$2.62
+195.8% from low
Target vs 52W High
$31.89
+269.1% vs high
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 39 | 82% | $257.58 | -2.0% |
| AMGN | Hold | 43 | 47% | $190.87 | -52.6% |
| GILD | Strong Buy | 37 | 81% | $362.68 | +150.6% |
| VRTX | Strong Buy | 36 | 81% | $438.34 | -13.2% |
| MRNA | Hold | 30 | 37% | $149.45 | -21.3% |
| REGN | Buy | 38 | 68% | $76.80 | -89.6% |
| NTRA | Strong Buy | 30 | 87% | $142.91 | -65.2% |
| RVMD | Strong Buy | 28 | 93% | $114.11 | -44.8% |